The National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative indicate that the urinary albumin/creatinine ratio is integral to the classification of chronic kidney disease. The urinary albumin/creatinine ratio has been found to be fundamentally important for both the diagnosis and the prognosis of chronic kidney disease. It is now recommended that all patients with diabetes or hypertension be screened annually with this test. The presence of albuminuria helps decide the medications for the treatment of hypertension. This review discusses the importance of urine albumin/creatinine ratio in chronic kidney disease.
Please complete the following form to access the white paper:
